Dakota Young
Nurse Practitioner · Fort Smith, ARNPI 1679205173
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (53.2%), food and beverage and education — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Medtronic at 39.7% of the total. Among nurse practitioner clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 221 payments — averaging $65.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$6K
- Coloplast$5K
- Axonics, Inc.$2K
- Bayer$620
- Sumitomo Pharma America, Inc.$222
- Johnson & Johnson$193
- plus $1K from 24 others
What the payments were for
- Speaking & faculty fees$380%
- Travel & lodging$7,73553%
- Food & beverage$6,71946%
- Education$540%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 62 | $5,779 |
| Coloplast | 40 | $4,690 |
| Axonics, Inc. | 14 | $1,594 |
| Bayer | 22 | $620 |
| Sumitomo Pharma America, Inc. | 13 | $222 |
| Johnson & Johnson(2 entities) | 9 | $193 |
| Myriad Genetic Laboratories, Inc. | 6 | $158 |
| Antares Pharma, Inc. | 11 | $158 |
| Pfizer | 8 | $152 |
| Abiomed | 1 | $128 |
| Neurocrine Biosciences, Inc. | 1 | $125 |
| Procept Biorobotics Corporation | 4 | $122 |
| Olympus America Inc. | 6 | $105 |
| Teleflex LLC | 3 | $76 |
| Urogen Pharma, Inc. | 3 | $52 |
| Boston Scientific | 1 | $51 |
| Merck | 3 | $46 |
| Astellas Pharma US Inc | 2 | $38 |
| Convatec Inc. | 1 | $27 |
| AbbVie | 1 | $24 |
| Innovation Technologies Inc | 1 | $23 |
| CSL Behring | 1 | $20 |
| Angiodynamics, Inc. | 1 | $20 |
| Progenics Pharmaceuticals, Inc. | 1 | $19 |
| Accord Healthcare, Inc. | 1 | $19 |
| Endo USA, Inc. | 1 | $19 |
| Kerecis Limited | 1 | $18 |
| Tolmar, Inc. | 1 | $18 |
| Novo Nordisk | 1 | $18 |
| Dendreon Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,546 in reported general payments places this provider in the 95th percentile of 697 nurse practitioner providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 46 | $35,838 |
| MyrbetriqMirabegron | 58 | $33,839 |
| Tamsulosin Hcl | 553 | $5,607 |
| Solifenacin Succinate | 134 | $3,801 |
| Estradiol | 51 | $2,888 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 107 | $2,848 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 19 | $2,273 |
| Methenamine Hippurate | 48 | $2,164 |
| Trimethoprim | 20 | $2,104 |
| Testosterone Cypionate | 64 | $1,829 |
| Dutasteride | 17 | $636 |
| Finasteride | 48 | $584 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 42 | $566 |
| Oxybutynin Chloride ErOxybutynin Chloride | 49 | $551 |
| Oxybutynin Chloride | 46 | $530 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $222 | $35,83846 claims |
| Astellas Pharma US IncMyrbetriq | $38 | $33,83958 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 697 nurse practitioner providers in Arkansas.
Other nurse practitioner in Fort Smith
- Kathleen MilamFort Smith$9K
- Lisa CokerFort Smith$8K
- Kathleen ToonFort Smith$7K
- Jenny HannaFort Smith$7K
- Jennifer JayFort Smith$6K
- Aida JonesFort Smith$5K
- Jacquelyn IsaacsFort Smith$4K
- Dana ReevesFort Smith$4K
- Merideth HanksRogers$157K
- Angela JonesJonesboro$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.